Ypsomed invests $250 million in a new U.S. manufacturing facility, enhancing local supply and creating jobs in Holly Springs, ...

In today’s Pharmaceutical Executive Daily, we cover Bristol Myers Squibb’s $1.5 billion acquisition of Orbital Therapeutics, ...

DTC programs aim to enhance patient access by offering lower prices, but require navigating complex regulatory and licensing ...

Another major pharmaceutical company is striking a deal with President Trump.

Bryan A. Liang, M.D., Ph.D., J.D., is executive director, Institute of Health Law Studies, California Western School of Law, and co-director, San Diego Center for Patient Safety, University of ...